Liquid biopsy in clinical pratice of non-small cell lung cancer (NSCLC): A multi-institutional experience
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Oncology"
DOI: 10.1093/annonc/mdz260.086
Abstract: Abstract Background Circulating tumor DNA (ctDNA) from liquid biopsy is a source of tumor genetic material for EGFR testing in NSCLC when resistance to I-II generations TKI-therapies occurs or upfront, in absence of tissue biopsy.… read more here.
Keywords: biopsy; biopsy clinical; liquid biopsy; oncology ... See more keywords